By Ellen Licking and Roger Longman
Apart from a few very lucky investors, the main financial beneficiaries of the genomic revolution have been the tool companies...
Molecular Diagnostics--From Tools to Tests
Instrument makers have made big money off the genomics revolution. But as the research market slows, companies are looking for new business opportunities. One area ripe for development: the molecular diagnostics market.